Project Details
Description
A Phase 2, Multicenter, Randomized, Double-Blind, Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17a-Propionate (CB-03-01) Solution 5%, Minoxidil Solution 5%, and Vehicle Solution
Status | Finished |
---|---|
Effective start/end date | 5/27/14 → 12/31/16 |
Funding
- INTREPID THERAPEUTICS, INC